What is a Technical Data Sheet (TDS)?
A TDS, or Technical Data Sheet, is a document that provides detailed technical information about a product: its specifications, performance, properties, usage, storage, and handling. In the pharmaceutical field, a TDS refers to the described qualities of an API, excipient, intermediate, or any material that supports decision‑making in sourcing, quality control, R&D, and regulatory review.
Why is a TDS Important in Pharmaceutical Trade?
- It helps pharma buyers and manufacturers verify whether a material meets required physical, chemical, and functional criteria before purchase.
- Aligns expectations between supplier and buyer about how the material behaves (solubility, stability, moisture content, particle size, etc.).
- TDS also supports documentation and compliance: specification comparisons, regulatory dossiers, COA (Certificate of Analysis), pharmacopeial reference, etc.
- Helps avoid supply chain problems—rejects, batch failures, incompatibilities—by ensuring upstream clarity.
What are the Core Principles Behind a Good Pharma‑Quality TDS?
- Clarity and Completeness: All relevant technical attributes must be defined (identity, assay, purity, moisture, physical properties, etc.).
- Standardized Test Methods: Data should refer to validated analytical or test methods, where possible, pharmacopeial or industry‑accepted methods.
- Traceability: Each data point in the TDS should be traceable to raw material sources, batches, reference standards, and documented tests.
- Relevance to Use / Application: TDS should include performance or functional specifications relevant to the material usage (formulation, stability, processing conditions).
- Version Control / Change Notification: When material or process changes, TDS must be updated and communicated to users; any significant change assessed for impact.
How Does a TDS Work in Practice for Pharma Products?
- The supplier creates a draft TDS detailing product attributes (chemical, physical, stability, etc.), often before commercial supply.
- Analytical & QC labs test a representative batch to fill in the TDS values (e.g. assay, impurity, moisture, particle size, etc.).
- Buyer/manufacturer reviews the TDS against their internal specifications / pharmacopeial monographs as a part of supplier qualification.
- Usage instructions, handling, storage are included in TDS so that downstream users (manufacturers, formulators) can handle the material correctly.
- Change control process: If raw material or supplier or process changes, the TDS is updated and revalidated; buyer notified.
- Ongoing monitoring: In production or post‑market, the TDS is used to compare batch COAs to the declared values; discrepancies trigger investigations.
Real‑World Examples in Pharma Supply Chains
- An excipient supplier on Pharmint provides a TDS that specifies moisture content, particle size, microbial limits, and certificate of analysis references so that a tablet manufacturer can decide fit for blend.
- An API manufacturer shares TDS including stability data under different storage conditions to overseas buyers so that they can plan packaging and shipping.
- A formulator needs TDS for excipients to decide compatibility with active ingredients (e.g. whether excipient will adsorb API, impact dissolution) before full scale batch.
Related Terms and Concepts
- Certificate of Analysis (COA) — actual test results vs the declared spec in TDS.
- Product Specification Sheet — similar in intent; TDS often is part of or aligned with the spec sheet.
- Pharmacopeial Compliance — TDS attributes may reference pharmacopeial monographs.
- Good Manufacturing Practice (GMP) — TDS helps in QA systems under GMP.
- Impurity Profile — data in TDS often includes impurity specs.
Technical Data Sheet FAQs
What information does a TDS typically include for APIs or excipients?
A TDS typically includes identity, assay/potency, purity/impurities, physical attributes (e.g., particle size, moisture content), solubility or functional specs, storage/handling conditions, and relevant test methods.
How is TDS different from a COA?
A TDS declares the expected technical attributes of a product type or batch; a COA shows actual results for a specific batch and verifies conformity to those expected values.
Is a TDS legally binding?
Generally, a TDS is not a legal document like a COA or regulatory registration, but in pharma procurement and regulatory review, it becomes de facto binding if relied upon in contracts or filings.
Can a TDS substitute for pharmacopeial monograph data?
No—TDS complements pharmacopeial standards but does not replace monograph methods and limits unless explicitly aligned or validated against such standards.
How frequently must a TDS be updated?
Whenever there are changes in raw material source, process, test methods, or regulatory/pharmacopeial requirements, or when user feedback or batch data show deviation.
Should a TDS include storage and handling instructions?
Yes—appropriate storage conditions (temperature, humidity, protection from light, etc.) and handling guidelines are important parts of TDS to ensure stability and quality.
Do international pharma buyers expect TDS in a specific format?
Yes—many buyers expect TDS in standard format (tables, method references, batch size, version date), often with traceable references like CAS, GMP‑certified supplier, and alignment with pharmacopeial or regulatory standards.
What happens if product batches deviate from TDS values?
Deviation may lead to non‑release of batch, investigation, revalidation, supplier audit, or contractual consequences. Buyers rely on the COA vs. the TDS declared specs.
Can TDS include safety or regulatory warnings?
Usually, TDS focuses on technical/data & functional aspects, but referencing safety (via SDS/MSDS) or regulatory compliance is typical, especially if material has hazard, controlled status or storage hazards.